NCT02147288

Brief Summary

The specific aim of this study is to improve post-operative wound care in the morbidly-obese body-contouring patient population following massive weight loss undergoing either panniculectomy or formal abdominoplasty, those patients undergoing complex abdominal wall reconstruction (i.e. ventral hernia repair) and breast reconstruction with acellular dermal matrix, as well as patients undergoing regular lipo-abdominoplasty by comparing the effectiveness of standard closed-suction drains versus the immediate application of continuous negative pressure via a NPWT (negative pressure wound therapy) device attached to non-compressible drains. Additionally, we aim to demonstrate increases both in cost-effectiveness and quality of life in these patients with the use of the NPWT wound care apparatus. Hypothesis 1 Continuous negative pressure devices decrease the incidence of wound complications in comparison with conventional closed suction drains when used in patients after massive weight loss undergoing body-contouring procedures (panniculectomies alone and formal abdominoplasties), and in patients undergoing VHR and breast reconstruction with acellular dermal matrix, as well as those undergoing regular lipo-abdominoplasty. Hypothesis 2 Although initially more costly than traditional closed suction drains, the use of continuous negative pressure devices will in the long-term result in lower total health care costs in the above-stated patient population due to a decreased need for additional procedures and/or clinical management, including surgical interventions, hospital admissions, administration of antibiotics, multiple follow-up office visits, and chronic wound care. Hypothesis 3 Better quality of life is associated with the use of continuous negative pressure devices compared to closed suction drains in these patient populations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 21, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 26, 2014

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

January 30, 2017

Completed
Last Updated

January 30, 2017

Status Verified

December 1, 2016

Enrollment Period

2.4 years

First QC Date

May 21, 2014

Results QC Date

August 11, 2016

Last Update Submit

December 6, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-operative Seroma Formation

    Quantitative assessment of fluid collection in pre-defined anatomic regions will be performed via ultrasound examination approximately two weeks following removal of drains (either JP or NPWT-associated)

    Two weeks following drain removal

Study Arms (10)

Breast Recon with acellular dermal matrix (ADM) on NPWT

EXPERIMENTAL
Device: Renasys*GO Negative Pressure Wound Therapy System

Lipoabdominoplasty on NPWT

EXPERIMENTAL

The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the lipoabdominoplasty patients enrolled in this arm.

Device: Renasys*GO Negative Pressure Wound Therapy System

Abdominoplasty on NPWT

EXPERIMENTAL

The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the abdominoplasty patients enrolled in this arm.

Device: Renasys*GO Negative Pressure Wound Therapy System

Ventral Hernia Repair (VHR) on NPWT

EXPERIMENTAL

The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the VHR patients enrolled in this arm.

Device: Renasys*GO Negative Pressure Wound Therapy System

Panniculectomy on NPWT

EXPERIMENTAL

The Smith\&Nephew Renasys\*GO device connected to non-compressible drains will be applied to the panniculectomy patients enrolled in this arm.

Device: Renasys*GO Negative Pressure Wound Therapy System

Breast Recon with ADM on Jackson-Pratt (JP) Drains

NO INTERVENTION

Standard of Care. The Jackson-Pratt (JP) drain is used following surgery to collect bodily fluids from the surgical site.

Abdominoplasty on JP Drains

NO INTERVENTION

Standard of Care. The Jackson-Pratt (JP) drain is used following surgery to collect bodily fluids from the surgical site.

Lipoabdominoplasty on JP Drains

NO INTERVENTION

Standard of Care. The Jackson-Pratt (JP) drain is used following surgery to collect bodily fluids from the surgical site.

Ventral Hernia Repair (VHR) on JP Drains

NO INTERVENTION

Standard of Care

Panniculectomy on JP Drains

NO INTERVENTION

Standard of care. The Jackson-Pratt (JP) drain is used following surgery to collect bodily fluids from the surgical site.

Interventions

Continuous, mechanical negative pressure wound therapy applied to drain in the immediate post-operative period (vs standard, closed-suction JP drains).

Also known as: Smith & Nephew, Inc.
Abdominoplasty on NPWTBreast Recon with acellular dermal matrix (ADM) on NPWTLipoabdominoplasty on NPWTPanniculectomy on NPWTVentral Hernia Repair (VHR) on NPWT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • total patients undergoing panniculectomy alone following massive weight loss
  • total patients undergoing formal abdominoplasty (including undermining of skin flaps, rectus fascia plication and liposuction) following massive weight loss
  • total non-massive weight loss patients undergoing formal lipo-abdominoplasty
  • total patients undergoing ventral hernia repair using acellular dermal matrix
  • total patients undergoing bilateral breast reconstruction using acellular dermal matrix with 30 breasts randomized to conventional closed suction (one breast left vs right) and 30 breasts randomized to continuous negative pressure devices (=60 breasts total)

You may not qualify if:

  • presence of necrotic tissue
  • untreated osteomyelitis
  • malignancy (except terminal patients for quality of life issues)
  • untreated malnutrition
  • use on exposed arteries, veins, or organs
  • use on non-enteric and unexplored fistulas Special precaution will be taken when using the NPWT device in patients on anticoagulants, exhibiting otherwise difficult hemostasis, or non-adherent patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University School of Medicine

New Haven, Connecticut, 06520, United States

Location

Related Publications (1)

  • Walker ME, Tsay C, Broer PN, Zhu VZ, Sturrock T, Ng R, Scoutt LM, Thomson JG, Kwei SL. A prospective, randomized-controlled pilot study comparing closed suction versus negative pressure drains for panniculectomy patients. J Plast Reconstr Aesthet Surg. 2018 Mar;71(3):438-439. doi: 10.1016/j.bjps.2017.11.013. Epub 2017 Nov 28. No abstract available.

MeSH Terms

Conditions

SeromaWound Infection

Condition Hierarchy (Ancestors)

InflammationPathologic ProcessesPathological Conditions, Signs and SymptomsInfections

Results Point of Contact

Title
Dr. Marc Walker
Organization
Yale University

Study Officials

  • J G Thomson, MD

    Section of Plastic and Reconstructive Surgery, Department of Surgery, Yale University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2014

First Posted

May 26, 2014

Study Start

January 1, 2012

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

January 30, 2017

Results First Posted

January 30, 2017

Record last verified: 2016-12

Locations